Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Twilight Litaka Pharma (formerly Litaka Pharmaceuticals) was historically a commercial-stage manufacturer of generic pharmaceuticals with a broad portfolio in anti-infectives, analgesics, anti-inflammatory, antipyretics, nutritionals, and other symptomatic and supportive therapies. Its products were widely marketed and accepted in India, with a focus on affordable and quality generics for paediatrics, geriatrics, and women's health. There is no evidence of new clinical-stage R&D in recent years, and reports indicate it is no longer an active/operating entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Twilight Litaka Pharma.